These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11004264)

  • 1. Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy.
    Yilmaz G; Esser P; Kociok N; Aydin P; Heimann K
    Am J Ophthalmol; 2000 Jul; 130(1):87-90. PubMed ID: 11004264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.
    Lange CAK; Stavrakas P; Luhmann UFO; de Silva DJ; Ali RR; Gregor ZJ; Bainbridge JWB
    Am J Ophthalmol; 2011 Sep; 152(3):406-412.e3. PubMed ID: 21723532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.
    Ogata N; Tombran-Tink J; Nishikawa M; Nishimura T; Mitsuma Y; Sakamoto T; Matsumura M
    Am J Ophthalmol; 2001 Sep; 132(3):378-82. PubMed ID: 11530051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased nitric oxide (NO) pathway metabolites in the vitreous fluid of patients with rhegmatogenous retinal detachment or diabetic traction retinal detachment.
    Diederen RM; La Heij EC; Deutz NE; Kessels AG; van Eijk HM; Hendrikse F
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):683-8. PubMed ID: 16267670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
    Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.
    Byon IS; Jeon HS; Kim HW; Lee SJ; Lee JE; Oum BS
    Curr Eye Res; 2013 Jul; 38(7):774-80. PubMed ID: 23725216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
    Li X; Jiang Y; Ye C; Li C
    Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
    Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
    Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy.
    Pinna A; Emanueli C; Dore S; Salvo M; Madeddu P; Carta F
    Ophthalmologica; 2004; 218(4):260-3. PubMed ID: 15258415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
    Sassa Y; Yoshida S; Ishikawa K; Asato R; Ishibashi T; Kono T
    Eye (Lond); 2016 May; 30(5):746-53. PubMed ID: 26915745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INCREASED COMPLEMENT LEVELS IN HUMAN VITREOUS ASPIRATES OF PROLIFERATIVE DIABETIC RETINOPATHY AND RETINAL DETACHMENT EYES.
    Manoharan N; Patnaik JL; Olson JL
    Retina; 2019 Nov; 39(11):2212-2218. PubMed ID: 30148749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy.
    Loukovaara S; Koivunen P; Inglés M; Escobar J; Vento M; Andersson S
    Acta Ophthalmol; 2014 Jun; 92(4):323-7. PubMed ID: 23718695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
    Chen W; Lu Q; Lu L; Guan H
    Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
    BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy.
    Oku H; Kida T; Sugiyama T; Hamada J; Sato B; Ikeda T
    Retina; 2001; 21(6):647-51. PubMed ID: 11756889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
    Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
    Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.